![Mark B. Benjamin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark B. Benjamin
President at Cyrus Biotechnology, Inc.
Profile
Mark B.
Benjamin is currently the President & Executive VP-Business Development at Cyrus Biotechnology, Inc. Previously, he worked as a Senior Business Development Executive at Rosetta Inpharmatics LLC from 1999 to 2001.
He also served as the Chief Business Officer at Nura, Inc. Additionally, he was a Trustee at Seattle Biomedical Research Institute.
Dr. Benjamin holds a doctorate degree from Harvard University and an undergraduate degree from the University of London.
Mark B. Benjamin active positions
Companies | Position | Start |
---|---|---|
Cyrus Biotechnology, Inc.
![]() Cyrus Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Cyrus Biotechnology, Inc. develops protein structure prediction and protein design software. The company was founded by Lucas Nivon, David Baker, Javier Castellanos and Yifan Song and is headquartered in Seattle, WA | President | - |
Former positions of Mark B. Benjamin
Companies | Position | End |
---|---|---|
Rosetta Inpharmatics LLC
![]() Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Corporate Officer/Principal | 2000-12-31 |
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Director/Board Member | - |
Nura, Inc.
![]() Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Training of Mark B. Benjamin
University of London | Undergraduate Degree |
Harvard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Nura, Inc.
![]() Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Health Technology |
Rosetta Inpharmatics LLC
![]() Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Cyrus Biotechnology, Inc.
![]() Cyrus Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Cyrus Biotechnology, Inc. develops protein structure prediction and protein design software. The company was founded by Lucas Nivon, David Baker, Javier Castellanos and Yifan Song and is headquartered in Seattle, WA | Commercial Services |
- Stock Market
- Insiders
- Mark B. Benjamin